Jilani I - Search Results

1

Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.

Ahmed M, Giles F, Joe Y, Weber DM, Jilani I, Manshouri T, Giralt S, De Lima M, Keating M, Albitar M. Ahmed M, et al. Among authors: jilani i. Eur J Haematol. 2003 Sep;71(3):174-8. doi: 10.1034/j.1600-0609.2003.00125.x. Eur J Haematol. 2003. PMID: 12930317

2

Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.

Rogers A, Joe Y, Manshouri T, Dey A, Jilani I, Giles F, Estey E, Freireich E, Keating M, Kantarjian H, Albitar M. Rogers A, et al. Among authors: jilani i. Blood. 2004 Apr 1;103(7):2799-801. doi: 10.1182/blood-2003-06-1840. Epub 2003 Oct 23. Blood. 2004. PMID: 14576069 Free article.

3

Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.

Jilani I, Estey E, Manshuri T, Caligiuri M, Keating M, Giles F, Thomas D, Kantarjian H, Albitar M. Jilani I, et al. Leukemia. 2003 Jan;17(1):114-9. doi: 10.1038/sj.leu.2402743. Leukemia. 2003. PMID: 12529667

4

Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia.

Washington LT, Jilani I, Estey E, Albitar M. Washington LT, et al. Among authors: jilani i. Leuk Res. 2002 Oct;26(10):899-902. doi: 10.1016/s0145-2126(02)00039-5. Leuk Res. 2002. PMID: 12163050

5

Differences in CD33 intensity between various myeloid neoplasms.

Jilani I, Estey E, Huh Y, Joe Y, Manshouri T, Yared M, Giles F, Kantarjian H, Cortes J, Thomas D, Keating M, Freireich E, Albitar M. Jilani I, et al. Am J Clin Pathol. 2002 Oct;118(4):560-6. doi: 10.1309/1WMW-CMXX-4WN4-T55U. Am J Clin Pathol. 2002. PMID: 12375643

6

Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.

Manshouri T, Do KA, Wang X, Giles FJ, O'Brien SM, Saffer H, Thomas D, Jilani I, Kantarjian HM, Keating MJ, Albitar M. Manshouri T, et al. Among authors: jilani i. Blood. 2003 Apr 1;101(7):2507-13. doi: 10.1182/blood-2002-06-1639. Epub 2002 Nov 21. Blood. 2003. PMID: 12446458 Free article.

7

In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.

Duzkale H, Jilani I, Orsolic N, Zingaro RA, Golemovic M, Giles FJ, Kantarjian H, Albitar M, Freireich EJ, Verstovsek S. Duzkale H, et al. Among authors: jilani i. Cancer Chemother Pharmacol. 2003 May;51(5):427-32. doi: 10.1007/s00280-003-0588-x. Epub 2003 Mar 26. Cancer Chemother Pharmacol. 2003. PMID: 12736761

8

Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.

Ma W, Kantarjian H, Zhang X, Jilani I, Sheikholeslami MR, Donahue AC, Ravandi F, Estey E, O'Brien S, Keating M, Giles FJ, Albitar M. Ma W, et al. Among authors: jilani i. Cancer Biomark. 2009;5(1):51-8. doi: 10.3233/CBM-2009-0583. Cancer Biomark. 2009. PMID: 19242062 Clinical Trial.

9

Myelodysplastic syndrome is not merely "preleukemia".

Albitar M, Manshouri T, Shen Y, Liu D, Beran M, Kantarjian HM, Rogers A, Jilani I, Lin CW, Pierce S, Freireich EJ, Estey EH. Albitar M, et al. Among authors: jilani i. Blood. 2002 Aug 1;100(3):791-8. doi: 10.1182/blood.v100.3.791. Blood. 2002. PMID: 12130488 Free article.

10

Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.

Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M. Ibrahim S, et al. Among authors: jilani i. Cancer. 2003 Apr 15;97(8):1914-9. doi: 10.1002/cncr.11264. Cancer. 2003. PMID: 12673718 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters